-+ 0.00%
-+ 0.00%
-+ 0.00%

SCISPARC’S SUBSIDIARY NEUROTHERA LABS GRANTED JAPANESE PATENT FOR ITS PROPRIETARY, INNOVATIVE THERAPEUTIC COMBINATION

Reuters·08/12/2026 12:25:08

Please log in to view news